The management of conditioned nutritional requirements in heart failure

被引:42
作者
Allard, Marc L.
Jeejeebhoy, Khursheed N.
Sole, Michael J. [1 ]
机构
[1] Univ Toronto, Toronto, ON, Canada
[2] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[3] Univ Hlth Network, Div Cardiol, Toronto, ON, Canada
关键词
congestive heart failure; nutrition; creatine; carnitine; taurine; coenzyme Q10; vitamin B; oxidative stress;
D O I
10.1007/s10741-006-9195-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients suffering from congestive heart failure exhibit impaired myocardial energy production, myocyte calcium overload and increased oxidative stress. Nutritional factors known to be important for myocardial energy production, calcium homeostasis and the reduction of oxidative stress, such as thiamine, riboflavin, pyridoxine, L-carnitine, coenzyme Q10, creatine and taurine are reduced in this patient population. Furthermore, deficiencies of taurine, carnitine, and thiamine are established primary causes of dilated cardiomyopathy. Studies in animals and limited trials in humans have shown that dietary replacement of some of these compounds in heart failure can significantly restore depleted levels and may result in improvement in myocardial structure and function as well as exercise capacity. Larger scale studies examining micronutrient depletion in heart failure patients, and the benefits of dietary replacement need to be performed. At the present time, it is our belief that these conditioned nutritional requirements, if unsatisfied, contribute to myocyte dysfunction and loss; thus, restoration of nutritional deficiencies should be part of the overall therapeutic strategy for patients with congestive heart failure.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 77 条
[1]   Acute and chronic effects of propinoyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure [J].
Anand, I ;
Chandrashekhan, Y ;
De Giuli, F ;
Pasini, E ;
Mazzoletti, A ;
Confortini, R ;
Ferrari, R .
CARDIOVASCULAR DRUGS AND THERAPY, 1998, 12 (03) :291-299
[2]  
[Anonymous], 1986, Myology : basic and clinical
[3]   Carnitine and its derivatives in cardiovascular disease [J].
Arsenian, MA .
PROGRESS IN CARDIOVASCULAR DISEASES, 1997, 40 (03) :265-286
[4]   TAURINE DECREASES LESION SEVERITY IN THE HEARTS OF CARDIOMYOPATHIC HAMSTERS [J].
AZARI, J ;
BRUMBAUGH, P ;
BARBEAU, A ;
HUXTABLE, R .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1980, 7 (04) :435-440
[5]   USEFULNESS OF TAURINE IN CHRONIC CONGESTIVE-HEART-FAILURE AND ITS PROSPECTIVE APPLICATION [J].
AZUMA, J ;
SAWAMURA, A ;
AWATA, N .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1992, 56 (01) :95-99
[6]  
BAGGIO E, 1993, CLIN INVESTIGATOR, V71, pS145
[7]  
Ball Adrianne M. M., 1998, Cardiology Clinics, V16, P665, DOI 10.1016/S0733-8651(05)70043-6
[8]   Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: A randomized, placebo-controlled study [J].
Berman, M ;
Erman, A ;
Ben-Gal, T ;
Dvir, D ;
Georghiou, GP ;
Stamler, A ;
Vered, Y ;
Vidne, BA ;
Aravot, D .
CLINICAL CARDIOLOGY, 2004, 27 (05) :295-299
[9]   NATURAL-HISTORY AND PATTERNS OF CURRENT PRACTICE IN HEART-FAILURE [J].
BOURASSA, MG ;
GURNE, O ;
BANGDIWALA, SI ;
GHALI, JK ;
YOUNG, JB ;
ROUSSEAU, M ;
JOHNSTONE, DE ;
YUSUF, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) :A14-A19
[10]   THIAMIN STATUS, DIURETIC MEDICATIONS, AND THE MANAGEMENT OF CONGESTIVE-HEART-FAILURE [J].
BRADY, JA ;
ROCK, CL ;
HORNEFFER, MR .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1995, 95 (05) :541-544